X4 Pharmaceuticals
XFOR
XFOR
35 hedge funds and large institutions have $296M invested in X4 Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.01% less ownership
Funds ownership: 0.42% → 0.42% (-0.01%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
35
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$4.03M | |
| 2 | +$3.74M | |
| 3 | +$2.85M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.29M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.11M |
Top Sellers
| 1 | -$3.53M | |
| 2 | -$1.68M | |
| 3 | -$504K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$460K |
| 5 |
Millennium Management
New York
|
-$299K |